Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation

Harnessing neoantigen specific CD4 T cells for cancer immunotherapy

(2020) Spencer E. Brightman et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity

(2019) Gwendolin S. Simper et al.   Pharmaceutics

Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome

(2018) Marie-Andrée Forget et al.   CLINICAL CANCER RESEARCH

The C-terminal extension landscape of naturally presented HLA-I ligands

(2018) Philippe Guillaume et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02

(2018) Gwendolin S. Simper et al.   Journal of Immunology Research

Membrane Ultrastructure and T Cell Activation

(2018) Johannes Pettmann et al.   Frontiers in Immunology

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

(2018) Magnus Pedersen et al.   OncoImmunology

Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors

(2017) Charles L. Dulberger et al.   IMMUNITY

Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01

(2017) Soumya G. Remesh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape

(2017) Phillip Pymm et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape

(2017) Phillip Pymm et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Variations in MHC Class II Antigen Processing and Presentation in Health and Disease

(2016) Emil R. Unanue et al.   Annual Review of Immunology

Autophagy proteins in antigen processing for presentation on MHC molecules

(2016) Christian Münz   IMMUNOLOGICAL REVIEWS

Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C

(2016) Lucy C. Sullivan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove

(2016) Curtis McMurtrey et al.   eLife

Early T Cell Activation: Integrating Biochemical, Structural, and Biophysical Cues

(2015) Bernard Malissen et al.   Annual Review of Immunology

T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

(2015) Jamie Rossjohn et al.   Annual Review of Immunology

Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide

(2015) Chihiro Motozono et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution

(2015) Marieke C. Verweij et al.   PLoS Pathogens

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

(2014) A. K. Moesta et al.   JOURNAL OF IMMUNOLOGY

The Adaptable Major Histocompatibility Complex (MHC) Fold: Structure and Function of Nonclassical and MHC Class I–Like Molecules

(2013) Erin J. Adams et al.   Annual Review of Immunology

Pathways of Antigen Processing

(2013) Janice S. Blum et al.   Annual Review of Immunology

Promotion and prevention of autoimmune disease by CD8+ T cells

(2013) David M. Gravano et al.   JOURNAL OF AUTOIMMUNITY

Signatures of mutational processes in human cancer

(2013) Ludmil B. Alexandrov et al.   NATURE

NK cell MHC class I specific receptors (KIR): from biology to clinical intervention

(2012) Ariane Thielens et al.   CURRENT OPINION IN IMMUNOLOGY

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

(2012) Patricia T. Illing et al.   NATURE

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

(2012) D. A. Ostrov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

(2011) D. M. Benson et al.   BLOOD

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

(2011) Tai-Ming Ko et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B

(2011) Julian P. Vivian et al.   NATURE

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans

(2011) Mark McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Innate or Adaptive Immunity? The Example of Natural Killer Cells

(2011) E. Vivier et al.   SCIENCE

Peptide binding predictions for HLA DR, DP and DQ molecules

(2010) Peng Wang et al.   BMC BIOINFORMATICS

NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients

(2009) Susanne E. Johansson et al.   CLINICAL IMMUNOLOGY

Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection

(2009) J. R. Vidal-Castineira et al.   JOURNAL OF VIROLOGY

HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection

(2009) G. Alter et al.   JOURNAL OF VIROLOGY

NetMHCpan, a method for MHC class I binding prediction beyond humans

(2008) Ilka Hoof et al.   IMMUNOGENETICS

Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

(2008) Golo Ahlenstiel et al.   JOURNAL OF CLINICAL INVESTIGATION

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence

(2008) Emma J. Petrie et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Natural killer cell–directed therapies: moving from unexpected results to successful strategies

(2008) Magali Terme et al.   NATURE IMMUNOLOGY

Structural basis for NKG2A/CD94 recognition of HLA-E

(2008) B. K. Kaiser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

KIR-HLA intercourse in HIV disease

(2008) Mary Carrington et al.   TRENDS IN MICROBIOLOGY

A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach

(2008) Peng Wang et al.   PLoS Computational Biology